During the past decade, several factors that inhibit insulin action on muscle have been described (de Bodo & Altszuler, 1958; Berson & Yalow, 1959; Vallance-Owen, 1960) . One of these anti-insulin substances, termed the synalbumin insulin antagonist, has been found to reside with albumin fractionated from the sera ofnormal human subjects (Vallance-Owen, Dennes & Campbell, 1958a,b; Lowy, Blanshard & Phear, 1961; Jervell, 1963) . A relationship between this humoral insulin inhibitor and diabetes mellitus is suggested by the elevated concentrations of this factor detected with albumin from diabetic subjects (Vallance-Owen & Lilley, 1961b) . Although fatty acids that are bound to albumin have been shown to exert an indirect inhibition of insulin (Randle, Garland, Hales & Newsholme, 1963) , the synalbumin antagonist does not have the characteristics ofa lipid and it has been postulated that it may be a polypeptide (VallanceOwen & Lilley, 1961a) .
Recently, it has been reported that the polypeptide B chain component of insulin is bound to human albumin after enzyme-mediated cleavage of insulin in vitro (Ensinck, Coombs, Nydick & Williams, 1963) . [For the purpose of brevity and in compliance with convention (Sanger, 1949) , the term 'B chain' refers throughout this paper to the phenylalanyl N-terminal chain of insulin.] In view of the extensive evidence to support a close struc-tural relationship between metabolite and antimetabolite in a variety of biochemical reactions (Martin, 1951; Modest, Foley & Farber, 1963) , it is conceivable that the B chain may act as an inhibitor to its parent insulin molecule.
The demonstration of an anti-insulin effect by the B chain would therefore justify the exploration of a possible relationship between this substance and the synalbumin insulin antagonist. As a part of a series of studies designed to test this hypothesis, this paper presents evidence that both the chemically and enzymically obtained B chain, in association with albumin, is capable ofabolishing the action of insulin as measured by the glucose uptake in the isolated rat hemidiaphragm.
MATERIALS AND METHODS In.rlin. Bovine insulin (6 x recrystallized; assayed at 22-4 units/mg.) was received as a gift from the British Insulin Manufacturers.
Human serum albumin. (i) Outdated crystalline human albumin (ether fractionation) was given by the Lister Institute, London, and further purified by a modification of the trichloroacetic acid-ethanol procedure of Debro, Tarver & Korner (1957) .
(ii) Serum was obtained from starved normal volunteers and from patients with diabetes mellitus. Albumin was extracted from the sera by the trichloroacetic acid-ethanol procedure. A 2 g. portion of the albumin extracted from the serum of diabetic patients was dissolved in 30 ml. of distilled water and submitted to gel ifitration in a column (220 cm. x 2-5 cm.) of Sephadex G-100, with development in water at 25°over 24 hr. (Flodin, 1962) . The protein distributed in the collected fractions was determined by measurement of the extinction at 280 m,u, and the eluent corresponding to albumin was freeze-dried. Then 1 g. was dissolved in 20 ml. of barbital buffer, pH 8-6 and I 0-05, and applied to a slot in a block (45 cm. x 20 cm. x 1 cm.) of Whatman cellulose. Electrophoresis in barbital buffer was performed over 24 hr. at 8 v/cm. The block was cut into 1 cm. segments and the albumin was eluted from the appropriate segments with distilled water. After vacuum concentration to 30 ml. the solution was extensively dialysed against distilled water and the protein freeze-dried. The albumin preparations obtained by extraction, gel filtration and electrophoresis were homogeneous as demonstrated by paper and immunoelectrophoresis.
Mercaptalbumin. Human mercaptalbumin (lot 1034) was purchased from the Nutritional Biochemical Corp. Cleveland, Ohio, U.S.A.
Preparation of crude extract of glutathione-insulin transhydrogenase. Acetone-dried powders from bovine liver were prepared according to the procedure of Tomizawa & Halsey (1959) . A 3-0 g. portion of powder was stirred with 36 ml. of 0-1 M-tris buffer, pH 7-5, and incubated for 30 min. at 37°. After centrifugation at 3000 rev./min. (2100g) for 10 min., the amber supernatant solution contained 20 mg. of protein/ml. as determined by the method of Lowry, Rosebrough, Farr & Randall (1951) .
Detection of insulin antagonism. The insulin-inhibitory activity of the various protein and polypeptide preparations was assayed by the rat-diaphragm procedure (VallanceOwen & Hurlock, 1954) . The freeze-dried fractions were dissolved in buffer (Gey & Gey, 1936) containing 300 mg. of glucose/100 ml., and any insoluble material was removed by centrifugation. Insulin was added (final concn. 1000 microunits/ml.) to the buffer-glucose solution alone and to buffer-glucose containing the protein fraction. In any one experiment, the glucose uptake was determined in (a) buffer alone (basal), (b) buffer plus added insulin (standard) and (c) buffer with dissolved protein plus insulin. The glucose uptake in three rat hemidiaphragms was measured after incubation of 2-0 ml. samples from each solution and the results are expressed in mg. of glucose/100 ml. of solution/ 10 mg. dry wt. over the 90 min. period of incubation.
RESULTS
Effect of human albumin on insulin action. The effect on insulin action of a variety of albumin preparations as measured in the isolated rat diaphragm is recorded in Table 1 . Albumin obtained from the sera ofnormal or diabetic subjects by ether fractionation or by trichloroacetic acid-ethanol extraction, at a concentration of 5 g./100 ml., resulted in inhibition of insulin action. The increased concentration of the inhibitor associated with albumin from diabetic patients is indicated by the continued antagonistic effect at 1-25 g./100 ml., whereas albumin from normal subjects was devoid of activity at this concentration. These findings confirm the original observations ofValiance-Owen et al. (1958a) and Vallance-Owen & Lilley (1961b) , and provide a standard of reference for comparison with subsequent results. Further, from Table 1 it is apparent   Table 1 . Effect of humman albumin on insulin action in the isolated rat diaphragm Albumin was prepared from human serum by the procedures described in the Materials and Methods section.
Each fraction was dissolved in 10 ml. of Gey & Gey (1936) buffer, pH 7-4, containing 300 mg. of glucose/100 ml. and 1000 microunits of insulin/ml. After incubation of 2-0 ml. of the appropriate solution with each of three rat hemidiaphragms at 370 for 90 min., the glucose uptake was determined. The uptake effected by 1000 microunits of insulin/ml. in buffer alone provided a reference standard. The (Hughes, 1949) . Di8sociation of antagoni8tic activity from albumin. Albumin extracted from human sera by trichloroacetic acid-ethanol was submitted to the following alternative procedures:
1. A 10 g. portion of albumin, dissolved in 200 ml. of 0.0155 M-sodium tetraborate-0 155 M-disodium hydrogen phosphate buffer, pH 8-6, was passed through a column (60 cm. x 5 cm.) of partially acetylated cellulose (Campbell & Stone, 1957) .
2. A 5 g. portion of albumin dissolved in 100 ml. of 0.15 M-sodium chloride was chromatographed through 100 ml. of Dowex 50 (X8; 100-200 mesh) equilibrated in saline (Antoniades, 1961 (Katchalski, Benjamin & Gross, 1957) , was placed in a Thunberg tube and left under nitrogen at 40 for 18 hr.
After the above procedures, the protein solutions were extensively dialysed against large volumes of distilled water and freeze-dried.
The processed albumin preparations no longer exhibited anti-insulin activity on muscle (Table 2 ). To ascertain whether or not any major alterations in the fundamental structure of albumin resulted from these manipulations, the treated albuimin preparations were submitted to extraction in trichloroacetic acid-ethanol solution in 0.01 M-0-1 Mphosphate buffer, pH 5-10, gel ifitration in Sephadex G-100 and G-200 in water, paper electrophoresis in barbital buffer, pH 8-6 and I 0 05, and immuno-diffusion in agar (Wilson & Pringle, 1954) against antisera prepared by the injection of human albumin into rabbits. In all instances the treated albumin preparations behaved similarly to albumin obtained from human serum by trichloroacetic acid-ethanol extraction. However, that the treatment with thiol had presumably caused a disruption of some of the intramolecular disulphide bonds was inferred by the presence of 1-7 thiol groups/mol. of treated albumin, as measured by the p-chloromercuribenzoate method of Boyer (1954) . In contrast, the albumin passed through partially acetylated cellulose or Dowex 50 (X8) contained 0-7 thiol group/mol., which is in keeping with the thiol content of normal human albumin (Cecil & McPhee, 1959) .
It seems reasonable to conclude, therefore, that the anti-insulin activity was associated with albumin but was not a property intrinsic to the albumin molecule. The failure to demonstrate insulin antagonism with albumin after passage through the sulphonic acid Dowex resin also suggests that the inhibitor may have been retained on the resin as a positively charged molecule. The loss of antagonism from albumin after exposure to thiol might be interpreted as indicating an association between albumin and antagonist by means of a disulphide bond or that a disulphide bond is essential to the biological activity (Boyer, 1959) . However, the former interpretation is difficult to reconcile with the loss of antagonism from albumin after chromatography on Dowex 50 or on partially acetylated cellulose, since it is unlikely that a covalent bond would be disrupted by these procedures. Therefore no definite conclusion can as yet be made on the mechanism of interaction between antagonist and albumin.
Effect of the B chain of insulin on insulin action in muscle. A 200 mg. portion of bovine insulin, dissolved in 20 ml. of 0-2 M-sodium sulphite-0-08 M- copper sulphate-8 M-urea solution, pH 10-2, was left at room temperature for 8-10 hr. (Dixon & Wardlow, 1960) . The sulpho-A and -B chains were separated by elution from a column (30 cm. x 2-5 cm.) of Dowex 50W (X2) with 2 7 M-formic acid-8 M-urea and 1-0 N-ammonia-8 m-urea respectively (Dixon & Wardlaw, 1960; Bailey & Cole, 1959) . The effluent containing the B chain was dialysed for 48 hr. against running water, concentrated to 20-30 ml. by rotary evaporation and submitted to gel filtration through a column (180 cm. x 2-0 cm.) of Sephadex G-25 in 10 N-ammonia. The sulpho-B chain, eluted at Vo (void volume), was freeze-dried after the removal of ammonia by vacuum concentration. The weight of polypeptide recovered was 110 mg. Reduction of the sulpho-B chain was performed by the following alternative methods: 1. A 50 mg. portion of chain, in a Thunberg tube, was dissolved in 5 ml. of a solution containing 500 ,umoles of thioglycollic acid, 30 ,umoles of EDTA and 40 m-moles of urea. After the pH was adjusted to 5 with methylamine, the solution was left at 40 for 16 hr. and transferred to a 250 ml. centrifuge bottle. The addition of 200 ml. of acetone resulted in the formation of a flocculent precipitate. After centrifugation, the acetone was decanted and the precipitate was resuspended in 5 ml. of distilled water. Acetone precipitation was repeated twice and the precipitate dried in vacuo. The weight of B chain recovered was 23 mg.
2. A 50 mg. portion of sulpho-B chain was dissolved in 50 ml. of anhydrous liquid ammonia and 5 mg. of sodium metal was added over 20 min. (Chen-lu, Yu-cang, & Geng-jun, 1961) . After the removal of ammonia under reduced pressure, the chain was dissolved in 10 ml. of 1-0 N-ammonia, and acetone precipitation performed as described above. The weight of polypeptide recovered was 27 mg.
The oxidized B chain was prepared from crystalline insulin by interaction with performic acid and differential precipitation by the method of Sanger (1949) .
It is apparent (Table 3 ) that a small but significant anti-insulin effect occurred with both the sulphoand reduced B chain preparations, whereas no antagonism resulted from the presence of the oxidized derivative. Since both the sulpho-and reduced chains are virtually insoluble in physiological buffers, it is possible that the minimal contra-insulin activity in relation to the amounts added was a function of their solubility. In contrast, the oxidized chain failed to cause any inhibition despite its complete solubility in the buffer.
From studies in which reduced 1311-labelled B chain, derived enzymically from 131I-labelled insulin, was shown to bind to albumin, Ensinck, Coombs, Williams & Vallence-Owen (1964) have postulated that the interaction between polypeptide and protein provided a means of solubilizing the B chain under physiological conditions. Therefore the following experiments were devised to determine if the B chain, in association with albumin, would cause an augmented anti-insulin effect. A 0-5 mg. portion of each of the three B chain derivatives was dissolved separately in 50 ,ul. of 2-7 M-formic acid-8 M-urea solution and added to 20 ml. of 0-1 M-tris buffer, pH 7-5, containing 1000 mg. of albumin that had been passed previously through partially acetylated cellulose and assayed as non-antagonistic (Table 2) . After aerobic incubation in a 25 ml. Erlenmeyer flask at 370 for 2 hr., the solutions were dialysed against distilled water for 72 hr. and freezedried.
The albumin preincubated with either the reduced or sulpho-B chain, at concentrations of 5 and 1-25g./100 ml., caused marked impairment of insulin action on muscle, in contrast with the lack of A 0-5-1-0 mg. portion of each B chain preparation was added to 10 ml. of Gey & Gey (1936) buffer and assayed with insulin as outlined in Vol. 94 153 Table 4 . Effect of non-antagonistic albumin and derivatives of the B chain on insulin action in the isolated rat hemidiaphragm A 0-5 mg. portion ofeach preparation of B chain, solubilized in 50,A. of 2-7 M-formic acid-8 M-urea, was incubated with 1000 mg. of non-antagonistic albumin (through partially acetylated cellulose; see Table. 2). The dialysed freeze-dried protein was assayed with insulin as outlined in inhibitory activity with albumin preincubated with the oxidized chain (Table 4) . Since the albumin employed in these experiments was initially devoid of anti-insulin activity, it seems reasonable to conclude that the inhibitory effect was due to the reduced and sulpho-chains. The enhanced anti-insulin activity of these preparations also suggests that an interaction had occurred between albumin and the two derivatives of the chain. Although the amount of chain in the form of complexes with albumin is uncertain, if maximum binding to albumin had occurred, it is calculated that approx. 6 ,ig. of chain associated with albumin caused an inhibition comparable with that obtained with 100 ,tg. of chain in buffer alone (Table 3 ). The observations that both the sulpho-and reduced B chain derivatives were capable ofexerting an anti-insulin effect, in contrast with the lack of such an effect by the oxidized chain, suggested that these differences might be accounted for by a modification of reactive groups on the chain during the oxidative cleavage of insulin. The essential dichotomy between the performic acid technique and that with sulphite is that the former causes an irreversible oxidation of both thiol groups of the chain to cysteic acid (Sanger, 1949) , whereas the latter results in the formation of a labile S-sulpho group that can be reconverted into a thiol group by thiol compounds (Swan, 1957) . Although it has been demonstrated that, in the presence of sulphite plus Cu2+, the disulphide groups of simple disulphide compounds are converted completely into S-sulpho groups (Kolthoff & Stricks, 1951) , it seemed possible that, under the conditions used in the present experiments, the reaction may not have gone to completion; and thus, if a thiol group could be demonstrated in both the sulpho-and reduced chain derivatives, this group could conceivably be essential to their anti-insulin activity. The thiol group analysis of the respective preparations of the chain employed in these experiments is shown in Table 5 . The sulpho-B chain derivative had a thiol content varying between approx. 0-5 and 0-9 thiol group/mol. and, after reaction with either thiol or liquid ammonia and sodium metal, further but incomplete reduction was accomplished.
In contrast, no free thiol group was demonstrable in the chain preparation obtained by the performic acid oxidation of insulin. Although the observed thiol content of these sulpho-B chain preparations seems difficult to reconcile with the complete conversion of thiol groups into S-sulpho groups in trypsinogen and chymotrypsin (Pechere, Dixon, Maybury, & Neurath, 1958) , in view of the relative lability of the S-sulphonate linkage, there is no simple means of ascertaining whether or not the reaction has gone to completion (Bailey & Cole, 1959) . The repeated observations of a significant concentration of thiol groups in the sulpho-B chain derivatives employed in these experiments suggests that incomplete conversion of thiol groups into S-sulpho groups has occurred, Additional evidence to support the postulate that the contra-insulin activity of the B chain may be related to a functional thiol group on the chain is provided by the loss of biological activity after reaction with alkylating agents. A 4 mg. portion of reduced B chain was dissolved in 0*1 ml. of 1-0 Nammonia-8 M-urea solution and 25 jul. was added to two separate 2 0 ml. volumes of 0 1 M-tris buffer, pH 7-5, containing 100 m-moles of iodoacetamide and N-ethylmaleimide respectively. A control of reduced B chain without alkylating agent was treated identically. After aerobic incubation at 370 for 2 hr., the solutions were dialysed against distilled water and freeze-dried. Then 1-0 mg. of each of the three preparations was dissolved in 50 pl.
of 2-7 M-formic acid-8 m-urea and added separately to 10 ml. of 0-1 m-tris buffer, pH 7-5, containing 500 mg. of albumin previously passed through partially acetylated cellulose and assayed as non-antagonistic (Table 2) . After incubation at 370 for 2 hr. the solutions were dialysed and freeze-dried.
The B chain preparations exposed to either iodoacetamide or N-ethylmaleimide no longer retained any demonstrable anti-insulin activity (Table 6 ). Although iodoacetamide and N-ethylmaleimide are not specific for thiol groups (Michaelis & Schubert, 1934; Boyer, 1959) , alkylation of this group proceeds more readily than for amino or phenolichydroxyl groups (Hellerman, 1937) . Hence it seems reasonable to suggest that the presence of a thiol group may be integral to the biological activity of the B chain in causing inhibition of insulin action on muscle.
Effect of insulin action of the albumin-B chain complex obtained by reduction of insulin by liver extracts in the presence of albumin. Reductive cleavage of insulin into its component A and B chains occurs after incubation of insulin with GSH and the enzyme glutathione-insulin transhydrogenase isolated from mammalian liver (Tomizawa, 1962; Katzen & Stetten, 1962) . Evidence has also been presented to indicate that 131I-labelled B chain, resulting from the scission of 131I-labelled insulin with GSH and partially purified glutathione-insulin transhydrogenase, is bound to human albumin (Ensinck et al. 1964) . In view of these findings, the following experiments were designed to determine if the B chain derived from insulin by enzymic reduction in the presence of human albumin was capable of exerting contra-insulin activity.
Since crude preparations of liver caused degradation of insulin comparable with that obtained with GSH and more highly purified preparations of the enzyme (Ensinck et al. 1964 ), extracts of acetonedried powder of bovine liver were used in the subsequent experiments. Because GSH is insoluble in organic solvents and therefore present in the powder, further addition of GSH to the system was not essential for the reaction to proceed and was omitted.
To 1000 mg. of albumin that has been previously passed through partially acetylated cellulose and assayed as non-antagonistic (Table 2) antagonistic albumin and liver extract, without insulin, served as controls and were handled in identical fashion. To separate the albumin-B chain complex from residual undegraded insulin and from the A chain resulting from the enzymic cleavage of insulin, as well as to inactivate the enzyme, the reactants were submitted to the following procedures (Ensinck et al. 1964) . Samples (1.0 ml.) from the albumin-insulin-liver extract solution were applied at 6 cm. origins of 20 sheets (42 cm. x 48 cm.) of Whatman no. 3 paper and submitted to descending chromatography in 0-1 M-barbitalbuffer, pH 86. After 5hr. the albumin had migrated 38-40 cm. from the origin. The papers were air-dried. A line at 35 cm. was cut parallel to the origin on each paper, and the proximal portions, containing residual undegraded insulin at the origin, were discarded. The remaining paper was cut into 1 cm. squares and the protein was eluted from the combined segments with 6-8 1. of water. After concentration to approx. 50 ml. by rotary evaporation, the protein solutionwas dialysed for 48 hr. against running tap water and freezedried (the A chain was removed during dialysis; Ensinck et al. 1964) . The protein, dissolved in 15 ml. of distilled water, was submitted to gel filtration in a column (180 cm. x 2 cm.) of Sephadex G-100, with development in distilled water at 25°. The eluent, containing the albumin occurring as a biphasic peak, was diluted to 200 ml. with distilled water, the pH adjusted to 5 0 with 1 N-acetic acid and the solution heated at 1000 for 5 min. This procedure was employed to effect dissociation of several polypeptides from albumin, among which was the B chain (Ensinck et al. 1964) , and also to inactivate any residual insulin-degrading enzyme (Mirsky, 1957) . The cooled solution was centrifuged at 4000 rev./min. (3750g) for 45 min. and the supernatant freeze-dried. The weight of the residual polypeptides derived from the thermally denatured albumin was 55 mg. The control solution, consisting of non-antagonistic albumin and liver extract, was submitted to the identical procedures outlined above. The weight of the residue after heat coagulation of control albumin was 48 mg.
Since it has been reported that the synalbumin insulin antagonist can be dissociated from albumin by heat (Vallance-Owen & Lilley, 1961a) , it was considered essential to demonstrate the presence of this antagonist in the supernatant fraction under the conditions employed above. An 8-0 g. portion of antagonistic albumin obtained by trichloroacetic acid-ethanol extraction of normal human serum (Table 1) was dissolved in 400 ml. of distilled water; the pH was adjusted to 5 0 with 1N-acetic acid and, after heating at 1000 for 5 min., the cooled solution was centrifuged and the supernatant fraction freeze-dried. The weight of residue recovered was 185 mg.
The effects of these preparations on insulin action Table 7 . Effect on insultin action in muscle of residues derived from albumin Details of the procedures are given in the text. Each of the following was assayed with insulin as outlined in Table 1 : (a) residue present in supernatant after centrifugation of heat-denatured antagonistic albumin; (b) residue present in supernatant after centrifugation of heat-denatured non-antagonistic albumin previously incubated with insulin and liver extract; (c) residue present in supernatant fraction after centrifugation of heat-denatured non-antagonistic albumin previously incubated with liver extract; (d) trichloroacetic acid-ethanol-extracted non-antagonistic albumin (see Table 2 ) previously incubated with liver extract; (e) trichloroacetic acid-ethanolextracted non-antagonistic albumin (see Table 2 ) previously incubated with insulin and liver extract; (f) albumin obtained by zone electrophoresis from (b). The results are given as means+ S.E.M.
Mean glucose uptake above basal (mg./100 ml./10 mg. of diaphragm) on muscle are recorded in Table 7 . The residue after thermal denaturation of antagonistic albumin exerted a marked inhibitory effect on insulin in the assay system. Similarly, the residual fraction from denatured non-antagonistic albumin with which insulin and liver extract had been treated also resulted in significant antagonism of insulin action on muscle, whereas that fraction obtained from denatured albumin reacted with liver extract without insulin had no anti-insulin activity.
To provide further evidence that the antagonistic activity resulting from incubation of insulin with liver extract was in the form of complexes with albumin, additional separation procedures were undertaken. A 2 g. portion of non-antagonistic albumin, 20 ,ug. of insulin and 40 ml. of liver extract were incubated as described above. The albumin was then extracted from the solution by the trichloroacetic acid-ethanol procedure. A control of non-antagonistic albumin and liver extract without insulin was processed in parallel. A 1 0 g. portion of the extracted albumin, dissolved in 15 ml. of barbital buffer, pH 8-6 and I 0 05, was submitted to electrophoresis in cellulose under the conditions described in the Materials and Methods section. The eluted albumin was freeze-dried after extensive dialysis against distilled water. Table 7 also shows that the original non-antagonistic albumin, after incubation with insulin and liver extract, exhibited a marked inhibitory effect on insulin action after trichloroacetic acidethanol extraction and purification by zone electrophoresis, whereas the control albumin, in which insulin was omitted from the initial reaction solution, had no anti-insulin effect. Therefore, it seems reasonable to conclude that the anti-insulin factor was derived from the insulin molecule after incubation with liver extract. Because the inhibitor was still present with albumin after the various procedures used to isolate albumin, it seems likely that it was bound to this protein. From the identification of 131I-labelled B chain as the component bound to albumin after the incubation of 131I-labelled insulin and liver extract (Ensinck et al. 1964) , and by analogy with the results given above in the present paper, it appears probable that this insulin inhibitor is the B chain of insulin.
DISCUSSION
The above observations support the conclusion that the action of insulin in promoting glucose entry into striated muscle is impaired by the presence of human albumin (Vallance-Owen et at. 1958a; Lowy et al. 1961; Jervell, 1964) . That the ability to antagonize insulin is related to albumin and not to another component of serum is adduced from the persistence of inhibitory activity with albumin isolated by several different methods. Because the anti-insulin effect can be dissociated from albumin by physicochemical procedures that do not alter the fundamental structure of the protein, it is concluded that the inhibitor is bound to the albumin molecule. The observed loss of inhibitor activity from albumin after passage through Dowex 50 and recent evidence that it can be eluted from this resin by alkali (J. W. Ensinck, R. J. Mahler & J. Vallance-Owen, unpublished work) is consistent with the behaviour of a positively charged molecule. The inhibitor is also dissociated from albumin after thermal denaturation of this protein and, from its disappearance after dialysis, a low molecular weight has been suggested for this compound (Valiance-Owen & Lilley, 1961a ).
The present results also indicate that the B chain of insulin is capable of inhibiting the action of insulin in muscle in vitro. The inability to demonstrate a major contra-insulin effect by the reduced polypeptide chain in the absence of albumin is possibly related to its low solubility in physiological buffer (Tomizawa, 1962; Katzen & Stetten, 1962) ; whereas the increased antagonistic activity of the B chain in the presence of albumin is consistent with the postulate of an enhanced solubility as a result of interaction with this serum protein.
It is significant that the B chain can be dissociated from its carrier albumin by thermal denaturation of the latter protein and is diffusible after this procedure. Moreover, after passage of the B chainalbumin complex through Dowex 50, the positively charged B chain is dissociated from albumin and retained on the resin. The B chain can be subsequently recovered by elution with alkali (J. W. Ensinck, R. J. Mahler & J. Valiance-Owen, unpublished work) . Thus these preliminary observations suggest that the B chain and synalbumin insulin antagonist are similar with respect to thermal stability, molecular weight and ionic charge.
Information on the role of inhibitors in metabolic processes is widely distributed in the literature (Martin, 1951; Modest et al. 1963) . Although extensive evidence has accumulated to support the structural relationship between a variety of biochemical compounds and their antimetabolites, the direct application of biological inhibitors to the action of polypeptide hormones is less well documented. Such an inhibitory effect is exemplified by the antagonism of oxytocin by the analogues 0-methyloxytocin and de(Pro(7) -Leu (8)-Gly(g)) -oxytocin (Law & Du Vigneaud, 1960; Boissonnas, Guttman, Berde & Konzett, 1961) . However, to our knowledge, no naturally occurring inhibitor has been described. In view of the antagonistic effect of the B chain on the action of the parent insulin molecule, it seems reasonable to consider that its anti-insulin activity may be related to the structural similarity Vol. 94 157 between antimetabolite and the B chain of intact insulin. It has been postulated that the action of arginine vasopressin on renal-tubular epithelium may be mediated through a series of thiol-disulphide interchange reactions involving the disulphide bond of vasopressin and thiol tissue receptors, thereby altering the structure of the membrane and permitting transference of water and selected solutes (Fong, Silver, Christman & Schwartz, 1960; Schwartz, Rasmussen, Schoessler, Silver & Fong, 1960) . Since the disulphide bonds of insulin are essential for activity and since after incubation of tissues with thiol-blocking agents insulin action is no longer demonstrable, a similar mechanism of thiol-disulphide interaction has been proposed to account for the metabolic acitivity of insulin (Cadenas, Kaji, Park & Rasmussen, 1961; Mirsky, 1963) . If such a mechanism were to pertain it is conceivable that the B chain might effect inhibition by a competition with insulin for available thiol receptor sites. A postulate ofsteric hindrance by the chain would infer a probable dissociation of the B chain from albumin near the cellular receptor site.
In support of this prediction it has been observed that, after the incubation of albumin-B chain preparations with intact diaphragm or cell-free muscle extracts, the reconstituted albumin was subsequently unable to inhibit insulin when reassayed (J. W. Ensinck, R. J. Mahler & J. VallanceOwen, unpublished work). The physiological role ofthe B chain remains to be established. Extensive evidence has accumulated to indicate an enzyme-mediated degradation of insulin by mammalian tissues (Mirsky, 1957) . Since the purified intracellular enzyme glutathioneinsulin transhydrogenase catalyses the reductive cleavage of insulin into its component chains (Tomizawa, 1962; Katzen & Stetten, 1962) , it is possible that the B chain represents a physiological product ofthis reaction. Indirect evidence that the products ofdegraded insulin occur in serum is indicated by the presence of 131I-labelled compounds other than insulin in mammalian serum after the injection of 131I-labelled insulin (Berson, Yalow, Bauman, Rothschild & Newerly, 1956 ). Further, radioactivity associated with albumin after the administration of 131I-labelled insulin to a rabbit has been tentatively identified as the 131I-labelled B chain (Ensinck et al. 1964) .
Although the B chain and the synalbumin insulin antagonist have not been proved to be identical, preliminary experiments comparing the two substances indicate a similarity in their physicochemical behaviour as well as in their biological activity in vitro. Therefore it seems appropriate to suggest that the B chain may be the synalbumin insulin antagonist and that the competition between the B chain and insulin for cellular receptor sites may provide a sensitive mechanism for the regulation of glucose assimilation by muscle.
